Xunming Biotechnology completes $35 million Series A+ funding round

Mars Finance News: On April 28, it was reported that Tech-Bio company Xunming Shengke (Aureka Biotechnologies) announced the completion of a $35 million Series A+ funding round.
This round was led by Sequoia China, with co-investments from Matrix Partners, Boyuan Capital, and continued investments from existing shareholders Five Sources Capital, Qiming Venture Partners, and Nuerli Capital.
So far, Xunming Shengke has completed nearly $100 million in funding through Series A and A+ rounds.
(VC CLUB)

View Original
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments